Clinical Trial Update: Pilot Study of Durvalumab and Vigil in Advanced Women's Cancers [Phase 2]

View source ↗

Summary

Phase 2 pilot study evaluating durvalumab with Vigil in advanced women's cancers has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Cervical Cancer
• Endometrial Cancer
• Fallopian Tube Cancer
• Ovarian Cancer
• Peritoneal Carcinoma
• Uterine Cancer

Drugs mentioned

• Durvalumab (durvalumab)
• Vigil

Snippet

Sponsor: Mary Crowley Medical Research Center | Conditions: Breast Cancer, Ovarian Cancer | Phase 2 | Status: COMPLETED